173 related articles for article (PubMed ID: 30654075)
1. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
3. Association of clinicopathological features of melanoma with total naevus count and a history of dysplastic naevi: a cross-sectional retrospective study within an academic centre.
Tan SY; Strazzulla LC; Li X; Park JJ; Lee SJ; Kim CC
Clin Exp Dermatol; 2018 Jul; 43(5):566-572. PubMed ID: 29450912
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and associations of high-mitotic-rate melanoma.
Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
[TBL] [Abstract][Full Text] [Related]
5. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.
McClain SE; Mayo KB; Shada AL; Smolkin ME; Patterson JW; Slingluff CL
Int J Dermatol; 2012 Apr; 51(4):420-6. PubMed ID: 22435430
[TBL] [Abstract][Full Text] [Related]
6. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
7. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
[TBL] [Abstract][Full Text] [Related]
8. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
10. Amelanotic melanoma.
Gong HZ; Zheng HY; Li J
Melanoma Res; 2019 Jun; 29(3):221-230. PubMed ID: 30672881
[TBL] [Abstract][Full Text] [Related]
11. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
[TBL] [Abstract][Full Text] [Related]
12. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
[TBL] [Abstract][Full Text] [Related]
13. Update and clinical use of imaging technologies for pigmented lesions of the skin.
O'Donnell AT; Kim CC
Semin Cutan Med Surg; 2012 Mar; 31(1):38-44. PubMed ID: 22361288
[TBL] [Abstract][Full Text] [Related]
14. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological, dermoscopic features and circumstances of diagnosis of amelanotic or hypomelanotic melanoma: A prospective multicentric study in the French private medical sector.
Lorier Roy E; Gourhant JY; Derancourt C; Jouan N; Dupuy A; Séi JF;
Ann Dermatol Venereol; 2024 Mar; 151(1):103249. PubMed ID: 38422599
[TBL] [Abstract][Full Text] [Related]
16. Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype.
Jaimes N; Braun RP; Thomas L; Marghoob AA
J Eur Acad Dermatol Venereol; 2012 May; 26(5):591-6. PubMed ID: 21585561
[TBL] [Abstract][Full Text] [Related]
17. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
18. Amelanotic malignant melanoma.
Adler MJ; White CR
Semin Cutan Med Surg; 1997 Jun; 16(2):122-30. PubMed ID: 9220551
[TBL] [Abstract][Full Text] [Related]
19. Dermatoscopy of amelanotic and hypomelanotic melanoma.
Stojkovic-Filipovic J; Kittler H
J Dtsch Dermatol Ges; 2014 Jun; 12(6):467-72. PubMed ID: 24825465
[TBL] [Abstract][Full Text] [Related]
20. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
